Antibiotic Cross-linked Micelles with Reduced Toxicity for Multidrug-Resistant Bacterial Sepsis Treatment
- 22 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (8), 9630-9642
- https://doi.org/10.1021/acsami.0c21459
Abstract
One potential approach to address the rising threat of antibiotic resistance is through novel formulations of established drugs. We designed antibiotic cross-linked micelles (ABC-micelles) by cross-linking the Pluronic F127 block copolymers with an antibiotic itself, via a novel one-pot synthesis in aqueous solution. ABC-micelles enhanced antibiotic encapsulation while also reducing systemic toxicity in mice. Using colistin, a hydrophilic, potent ″last-resort” antibiotic, ABC-micelle encapsulation yield was 80%, with good storage stability. ABC-micelles exhibited an improved safety profile, with a maximum tolerated dose of over 100 mg/kg colistin in mice, at least 16 times higher than the free drug. Colistin-induced nephrotoxicity and neurotoxicity were reduced in ABC-micelles by 10–50-fold. Despite reduced toxicity, ABC-micelles preserved bactericidal activity, and the clinically relevant combination of colistin and rifampicin (co-loaded in the micelles) showed a synergistic antimicrobial effect against antibiotic-resistant strains of Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. In a mouse model of sepsis, colistin ABC-micelles showed equivalent efficacy as free colistin but with a substantially higher therapeutic index. Microscopic single-cell imaging of bacteria revealed that ABC-micelles could kill bacteria in a more rapid manner with distinct cell membrane disruption, possibly reflecting a different antimicrobial mechanism from free colistin. This work shows the potential of drug cross-linked micelles as a new class of biomaterials formed from existing antibiotics and represents a new and generalized approach for formulating amine-containing drugs.Funding Information
- Ministry of Science and Technology of the People's Republic of China (2018YFA0902102)
- Tianjin University
- National Natural Science Foundation of China (21621004, 32071384)
- Central People's Government of the People's Republic of China
This publication has 69 references indexed in Scilit:
- The critical role of catalase in prooxidant and antioxidant function of p53Cell Death & Differentiation, 2012
- Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokineticsJournal of Antimicrobial Chemotherapy, 2011
- Colistin-functionalised CdSe/ZnS quantum dots as fluorescent probe for the rapid detection of Escherichia coliBiosensors and Bioelectronics, 2011
- Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial InfectionJournal of the American Chemical Society, 2011
- Breaking the wall: targeting of the endothelium by pathogenic bacteriaNature Reviews Microbiology, 2009
- Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imagingBiomaterials, 2007
- Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Diversity of structures and properties among catalasesCellular and Molecular Life Sciences, 2004
- Reviving the antibiotic miracle?Science, 1994
- Effects of Large Doses of Colistin Sulphomethate Sodium on Renal FunctionBMJ, 1970